trial · primary record
Fezolinetant
Hot Flashes
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2028-04-30 |
| Primary endpoint | Mean change from baseline in the frequency of moderate to severe vasomotor symptoms (VMS) |
| Registry ID | NCT07829653 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:37.498Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07829653
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Fezolinetant · approval
- Fezolinetant · compound